170 related articles for article (PubMed ID: 28599655)
1. Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.
Kato Y; Ochiai K; Kawakami S; Nakao N; Azakami D; Bonkobara M; Michishita M; Morimatsu M; Watanabe M; Omi T
BMC Vet Res; 2017 Jun; 13(1):170. PubMed ID: 28599655
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor REIC/DKK-3 and co-chaperone SGTA: Their interaction and roles in the androgen sensitivity.
Ochiai K; Morimatsu M; Kato Y; Ishiguro-Oonuma T; Udagawa C; Rungsuriyawiboon O; Azakami D; Michishita M; Ariyoshi Y; Ueki H; Nasu Y; Kumon H; Watanabe M; Omi T
Oncotarget; 2016 Jan; 7(3):3283-96. PubMed ID: 26658102
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning of canine co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α (SGTA) and investigation of its ability to suppress androgen receptor signalling in androgen-independent prostate cancer.
Kato Y; Ochiai K; Michishita M; Azakami D; Nakahira R; Morimatsu M; Ishiguro-Oonuma T; Yoshikawa Y; Kobayashi M; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Omi T
Vet J; 2015 Nov; 206(2):143-8. PubMed ID: 26346258
[TBL] [Abstract][Full Text] [Related]
4. The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α.
Azakami D; Nakahira R; Kato Y; Michishita M; Kobayashi M; Onozawa E; Bonkobara M; Kobayashi M; Takahashi K; Watanabe M; Ishioka K; Sako T; Ochiai K; Omi T
Vet Comp Oncol; 2017 Jun; 15(2):557-562. PubMed ID: 26762899
[TBL] [Abstract][Full Text] [Related]
5. Tumor suppressor REIC/Dkk-3 and its interacting protein SGTA inhibit glucocorticoid receptor to nuclear transport.
Iwata T; Sadahira T; Ochiai K; Ueki H; Sasaki T; Haung P; Araki M; Watanabe T; Nasu Y; Watanabe M
Exp Ther Med; 2020 Aug; 20(2):1739-1745. PubMed ID: 32765682
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of the cochaperone SGTA results in the suppression of androgen and PI3K/Akt signaling and inhibition of prostate cancer cell proliferation.
Trotta AP; Need EF; Selth LA; Chopra S; Pinnock CB; Leach DA; Coetzee GA; Butler LM; Tilley WD; Buchanan G
Int J Cancer; 2013 Dec; 133(12):2812-23. PubMed ID: 23740762
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and tumour suppressor function analysis of canine REIC/Dkk-3 in mammary gland tumours.
Ochiai K; Watanabe M; Azakami D; Michishita M; Yoshikawa Y; Udagawa C; Metheenukul P; Chahomchuen T; Aoki H; Kumon H; Morimatsu M; Omi T
Vet J; 2013 Sep; 197(3):769-75. PubMed ID: 23732075
[TBL] [Abstract][Full Text] [Related]
8. Subdomain structure of the co-chaperone SGTA and activity of its androgen receptor client.
Trotta AP; Need EF; Butler LM; Selth LA; O'Loughlin MA; Coetzee GA; Tilley WD; Buchanan G
J Mol Endocrinol; 2012 Oct; 49(2):57-68. PubMed ID: 22693264
[TBL] [Abstract][Full Text] [Related]
9. Properties of the feline tumour suppressor reduced expression in immortalized cells (REIC/Dkk-3).
Ochiai K; Oda H; Shono S; Kato Y; Sugihara S; Nakazawa S; Azakami D; Michishita M; Onozawa E; Bonkobara M; Sako T; Shun-Ai L; Ueki H; Watanabe M; Omi T
Vet Comp Oncol; 2017 Dec; 15(4):1181-1186. PubMed ID: 27353749
[TBL] [Abstract][Full Text] [Related]
10. Small glutamine-rich tetratricopeptide repeat-containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome.
Butler MS; Yang X; Ricciardelli C; Liang X; Norman RJ; Tilley WD; Hickey TE
Fertil Steril; 2013 Jun; 99(7):2076-83.e1. PubMed ID: 23433514
[TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase.
Abarzua F; Sakaguchi M; Takaishi M; Nasu Y; Kurose K; Ebara S; Miyazaki M; Namba M; Kumon H; Huh NH
Cancer Res; 2005 Nov; 65(21):9617-22. PubMed ID: 16266978
[TBL] [Abstract][Full Text] [Related]
12. Targeting Binding Function-3 of the Androgen Receptor Blocks Its Co-Chaperone Interactions, Nuclear Translocation, and Activation.
Lallous N; Leblanc E; Munuganti RS; Hassona MD; Nakouzi NA; Awrey S; Morin H; Roshan-Moniri M; Singh K; Lawn S; Yamazaki T; Adomat HH; Andre C; Daugaard M; Young RN; Guns ES; Rennie PS; Cherkasov A
Mol Cancer Ther; 2016 Dec; 15(12):2936-2945. PubMed ID: 27765852
[TBL] [Abstract][Full Text] [Related]
13. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
[TBL] [Abstract][Full Text] [Related]
14. The cochaperone SGTA (small glutamine-rich tetratricopeptide repeat-containing protein alpha) demonstrates regulatory specificity for the androgen, glucocorticoid, and progesterone receptors.
Paul A; Garcia YA; Zierer B; Patwardhan C; Gutierrez O; Hildenbrand Z; Harris DC; Balsiger HA; Sivils JC; Johnson JL; Buchner J; Chadli A; Cox MB
J Biol Chem; 2014 May; 289(22):15297-308. PubMed ID: 24753260
[TBL] [Abstract][Full Text] [Related]
15. Androgen receptor protein levels are significantly reduced in serous ovarian carcinomas compared with benign or borderline disease but are not altered by cancer stage or metastatic progression.
Butler MS; Ricciardelli C; Tilley WD; Hickey TE
Horm Cancer; 2013 Jun; 4(3):154-64. PubMed ID: 23443946
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1.
Ochiai K; Watanabe M; Ueki H; Huang P; Fujii Y; Nasu Y; Noguchi H; Hirata T; Sakaguchi M; Huh NH; Kashiwakura Y; Kaku H; Kumon H
Biochem Biophys Res Commun; 2011 Aug; 412(2):391-5. PubMed ID: 21835165
[TBL] [Abstract][Full Text] [Related]
17. The Downregulation of the Expression of CD147 by Tumor Suppressor REIC/Dkk-3, and Its Implication in Human Prostate Cancer Cell Growth Inhibition.
Mori A; Watanabe M; Sadahira T; Kobayashi Y; Ariyoshi Y; Ueki H; Wada K; Ochiai K; Li SA; Nasu Y
Acta Med Okayama; 2017 Apr; 71(2):135-142. PubMed ID: 28420895
[TBL] [Abstract][Full Text] [Related]
18. REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells.
Chen J; Watanabe M; Huang P; Sakaguchi M; Ochiai K; Nasu Y; Ouchida M; Huh NH; Shimizu K; Kashiwakura Y; Kaku H; Kumon H
Int J Mol Med; 2009 Dec; 24(6):789-94. PubMed ID: 19885619
[TBL] [Abstract][Full Text] [Related]
19. Expression of REIC/Dkk-3 in normal and hyperproliferative epidermis.
Du G; Kataoka K; Sakaguchi M; Abarzua F; Than SS; Sonegawa H; Makino T; Shimizu T; Huh NH
Exp Dermatol; 2011 Mar; 20(3):273-7. PubMed ID: 21323747
[TBL] [Abstract][Full Text] [Related]
20. An N-terminal 78 amino acid truncation of REIC/Dkk-3 effectively induces apoptosis.
Abarzua F; Kashiwakura Y; Takaoka M; Watanabe M; Ochiai K; Sakaguchi M; Iwawaki T; Tanimoto R; Nasu Y; Huh NH; Kumon H
Biochem Biophys Res Commun; 2008 Oct; 375(4):614-8. PubMed ID: 18727918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
